Medicare Enrolled

Dr. Kevin Osgood, MD

Rheumatology · West Lake Hills, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4701 BEE CAVES RD STE 201, West Lake Hills, TX 78746
5125184992
In practice since 2007 (19 years)
NPI: 1942356563 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Osgood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Osgood? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Osgood

Dr. Kevin Osgood is a rheumatology in West Lake Hills, TX, with 19 years in practice. Based on federal Medicare data, Dr. Osgood performed 78,913 Medicare services across 793 unique beneficiaries.

Between the years covered by Open Payments, Dr. Osgood received a total of $31,269 from 51 pharmaceutical and/or device companies across 1403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Osgood is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 18% volume in TX$ $31,269 industry payments

Medicare Practice Summary

Medicare Utilization ↗
78,913
Medicare services
Top 18% in TX for rheumatology
793
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,153 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)30,600$4$8
Tocilizumab injection (Actemra)24,722$5$11
Golimumab infusion (Simponi Aria)11,667$10$26
Abatacept infusion (Orencia)7,375$33$106
Infliximab infusion (Remicade)1,980$25$63
Denosumab injection (Prolia/Xgeva)1,140$18$43
Office visit, established patient (30-39 min)627$94$394
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less248$52$216
Drug injection, under skin or into muscle174$11$45
Office visit, established patient (20-29 min)75$68$279
Steroid injection (triamcinolone)72$1$5
New patient office visit (45-59 min)64$132$510
Administration of chemotherapy into vein, each additional hour63$23$92
Administration of chemotherapy into vein, 1 hour or less51$105$439
Injection of additional new drug or substance into vein30$11$51
Blood draw (venipuncture)14$8$18
New patient office visit (30-44 min)11$80$343
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.0% high complexity
72.0% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,269
Total received (2018-2024)
Avg $4,467/year across 7 years
Top 14% in TX for rheumatology
51
Companies
1,403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,152 (80.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,117 (19.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,580
2023
$2,626
2022
$3,709
2021
$4,577
2020
$2,901
2019
$4,718
2018
$10,159

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$11,080
UCB, Inc.
$2,745
Amgen Inc.
$2,688
PFIZER INC.
$1,798
ABBVIE INC.
$1,386
Lilly USA, LLC
$1,350
Novartis Pharmaceuticals Corporation
$1,153
GENZYME CORPORATION
$945
AbbVie Inc.
$828
AbbVie, Inc.
$757
E.R. Squibb & Sons, L.L.C.
$627
GlaxoSmithKline, LLC.
$619
Celgene Corporation
$587
Genentech USA, Inc.
$571
Horizon Therapeutics plc
$550
AstraZeneca Pharmaceuticals LP
$449
Aurinia Pharma U.S., Inc.
$436
Horizon Pharma plc
$251
Mallinckrodt Hospital Products Inc.
$243
Mallinckrodt LLC
$237
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
SANOFI-AVENTIS U.S. LLC
$200
Johnson & Johnson Health Care Systems Inc.
$150
Merck Sharp & Dohme Corporation
$137
Actelion Pharmaceuticals US, Inc.
$122
Mallinckrodt Enterprises LLC
$103
Octapharma USA, Inc.
$98
Fresenius Kabi USA, LLC
$93
Abbott Laboratories
$76
Hikma Pharmaceuticals USA
$69
Radius Health, Inc.
$66
Antares Pharma, Inc.
$64
Sobi, Inc
$59
Organon Llc
$50
Grifols USA, LLC
$48
Takeda Pharmaceuticals U.S.A., Inc.
$40
Alexion Pharmaceuticals, Inc.
$39
West-Ward Pharmaceuticals
$39
ANI Pharmaceuticals, Inc.
$38
MEDAC PHARMA, INC.
$38
Organon LLC
$29
Ultragenyx Pharmaceutical Inc.
$27
SOBI, INC
$24
Fidia Pharma USA Inc.
$22
CSL Behring
$20
Cranial Technologies, Inc
$18
HOSPIRA, INC.
$17
Eisai Inc.
$17
Boston Scientific Corporation
$17
Biocon Biologics Inc
$15
Daiichi Sankyo Inc.
$12
Top 3 companies account for 52.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Dayvigo · Doc Band · EVENITY · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · Gamunex-C · HADLIMA · HUMIRA · HYMOVIS · Hizentra · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Octrode SCS Leads · Otezla · Otrexup · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · TRULICITY · Tymlos · UPTRAVI · Uloric · Ultomiris · VIMOVO · XELJANZ · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $40 per 100 Medicare services performed
Looking for a rheumatology in West Lake Hills?
Compare rheumatologys in the West Lake Hills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
26
Per 100K population
2.0
County median income
$97,169
Nearest hospital
THE HOSPITAL AT WESTLAKE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Osgood is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Osgood experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Osgood performed 30,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Osgood receive payments from pharmaceutical companies?
Yes. Dr. Osgood received a total of $31,269 from 51 companies across 1,403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Osgood's costs compare to other rheumatologys in West Lake Hills?
Dr. Osgood's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Osgood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →